2024 annual financial data
XORTX Therapeutics 2024 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -3,920,582 USD and net income was -3,154,259.5 USD.
Operating cash flow was -3,678,648 USD.
Get free XORTX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,920,582 USD
- Net income
- -3,154,259.5 USD
- Operating cash flow
- -3,678,648 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all XORTX Therapeutics financial years